Bristol-Myers Squibb (BMY) Raises Quarterly Dividend 2.5% to $0.41; 3.1% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Bristol-Myers Squibb (BMY), Vedanta Biosciences Report New Clinical Collaboration to Evaluate OPDIVO (Nivolumab) & VE800 in Patients with Advanced or Metastatic Cancers
December 10, 2018 5:56 AM ESTBristol-Myers Squibb Company (NYSE: BMY) and Vedanta Biosciences today announced a clinical trial collaboration to evaluate Bristol-Myers... More
BMO Capital Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform
December 6, 2018 3:59 AM ESTBMO Capital analyst Alex Arfaei upgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Market Perform to Outperform with a price target of $60.00 (from $56.00).
The analyst upgrades the name citing expectations for upside to consensus IO and Margin estimates.
Arfaei commented, "The... More
